Learn More
TARGETMOL CHEMICALS INC LISAFTOCLAX 5MG

Supplier: TARGETMOL CHEMICALS INC T104835MG
Also available in 1 mg 10 mg 25 mg 50 mg 100 mg 1 mL 10 mM (in DMSO) and bulk. Please contact Fisher for quotes. Lisaftoclax (Bcl-2/Bcl-xl inhibitor 1) is an oral dual inhibitor of Bcl-2 and Bcl-xl with IC50 values of 2 nM and 5.9 nM for Bcl-2 and Bcl-xl respectively. Lisaftoclax is used to treat chronic lymphocytic leukemia (CLL) by inhibiting the action of the BCL-2 protein which promotes the death of leukemia cells. purity: 98%
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.